EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
about
Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic miceInterplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the HostEBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda.Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.EBV and HIV-Related LymphomaEpstein-Barr virus LMP2A imposes sensitivity to apoptosis.LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activationIcaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.Evaluation of Epstein-Barr virus latent membrane protein 2 specific T-cell receptors driven by T-cell specific promoters using lentiviral vectorEpstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.The Smac mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and Smac.Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation.c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.NF-κB as a target for oncogenic viruses.Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22Higher methylation intensity induced by EBV LMP1 via NF-κB/DNMT3b signaling contributes to silencing of PTEN geneGammaherpesvirus and lymphoproliferative disorders in immunocompromised patientsInfection, mutation, and cancer evolution.Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T/NK-cell proliferation.Exosomal sorting of the viral oncoprotein LMP1 is restrained by TRAF2 association at signalling endosomes.EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model.Epstein-Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance.The LMP1 promoter can be transactivated directly by NF-kappaB.Mutational landscape of B-cell post-transplant lymphoproliferative disorders.Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.Clinicopathologic and Immunophenotypic Features of Primary Intestinal Extranodal NK/T-Cell Lymphoma, Nasal Type.Intracellular signaling controlled by the endosomal-exosomal pathway.Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A.Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
P2860
Q27345929-C1C5DAFD-B19B-4FCB-AADC-E306FEE4D0D5Q28080198-419648FE-74A0-4BF1-8F70-F56966C9AC29Q30390920-BDCD37AE-880B-4E27-AE87-A2BCB2FB6C41Q33889404-47389016-EB69-4E18-A55F-6AD2D3CCA86EQ34267599-0EE46D91-F855-464D-B605-A424187D502DQ34549450-B12F723A-1DA4-408A-BE31-DE6532D4DEC2Q34734755-A9B9AF82-6909-4067-9ABF-609B20E0657CQ35052575-D73522BB-445E-40F3-8322-ED157587D5D7Q35107719-85173D26-CC97-4D9B-A587-F6814F698DE9Q35238310-9881AC84-BDFE-4751-B1C3-60C63A062B88Q35238430-A8A1154F-9C9E-4A35-A34E-1FDCE9FA023FQ35903344-E78B6297-F077-4B61-835C-4D015FE9E265Q37149898-822A4078-02E7-470D-B26B-33B92D7B968EQ37192244-F1B53C87-FB3B-4BD6-AA7B-A2958FE00B24Q37374081-4D71AD77-35EC-45A7-AC73-F42C7C86E8C7Q37399274-900644E6-C819-4639-AC99-926A704C767CQ37457770-FD1B0D9F-7E56-4B2C-95E9-057E094B46B1Q37865141-736D2CB4-4693-4177-A1DC-FF759B3B5ED0Q38000019-219F0BC9-9F33-48AF-B687-5E3F9813063EQ38180332-3707CAF7-07D8-4125-9AF3-C1DAC71FF942Q38694375-34CFE995-F54B-488B-B7FD-9ECD37DBE3C2Q38998165-27995109-81B7-4D0C-81FB-CD3EF5A9FB44Q39544175-853BE377-5F30-45AC-ADE8-D904C7E64014Q39652489-680E8E78-2CD2-4826-A34E-C78CD43E557CQ39765355-E37B7CEF-929C-4D20-A762-D515B51E4F6AQ39874197-23E1CEB3-2A95-47CF-984C-907061291F9FQ40238236-E000C526-449E-4E2A-AE94-8B7F690176EFQ40269570-66876482-945E-4C67-993B-A2238F96B2EAQ40375799-45D15B4B-F931-465A-9E31-30DA592C8D89Q40726983-DD6DBDA5-3843-49E0-B97B-8FB759ECC43AQ41933242-74902B2D-3869-4E8F-A3E2-CF9CF7EB1F8DQ55314625-13EC06CA-F73C-4E4A-AF6C-8ABDAE4B0962Q58704308-A77927B2-EA82-4796-A4B2-BDB7551B8A85
P2860
EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
EBV LMP2A affects LMP1-mediate ...... y regulating TRAF2 expression.
@ast
EBV LMP2A affects LMP1-mediate ...... y regulating TRAF2 expression.
@en
type
label
EBV LMP2A affects LMP1-mediate ...... y regulating TRAF2 expression.
@ast
EBV LMP2A affects LMP1-mediate ...... y regulating TRAF2 expression.
@en
prefLabel
EBV LMP2A affects LMP1-mediate ...... y regulating TRAF2 expression.
@ast
EBV LMP2A affects LMP1-mediate ...... y regulating TRAF2 expression.
@en
P2093
P2860
P4510
P1433
P1476
EBV LMP2A affects LMP1-mediate ...... y regulating TRAF2 expression.
@en
P2093
Darya Bubman
Ethel Cesarman
Ilaria Guasparri
P2860
P304
P356
10.1182/BLOOD-2007-03-080309
P407
P577
2008-01-29T00:00:00Z